BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 23595349)

  • 1. There is a 'uc' in mucus, but is there mucus in UC?
    McGuckin MA; Hasnain SZ
    Gut; 2014 Feb; 63(2):216-7. PubMed ID: 23595349
    [No Abstract]   [Full Text] [Related]  

  • 2. Thickness and continuity of the adherent colonic mucus barrier in active and quiescent ulcerative colitis and Crohn's disease.
    Strugala V; Dettmar PW; Pearson JP
    Int J Clin Pract; 2008 May; 62(5):762-9. PubMed ID: 18194279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An intercrypt subpopulation of goblet cells is essential for colonic mucus barrier function.
    Nyström EEL; Martinez-Abad B; Arike L; Birchenough GMH; Nonnecke EB; Castillo PA; Svensson F; Bevins CL; Hansson GC; Johansson MEV
    Science; 2021 Apr; 372(6539):. PubMed ID: 33859001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microbial modulation of innate defense: goblet cells and the intestinal mucus layer.
    Deplancke B; Gaskins HR
    Am J Clin Nutr; 2001 Jun; 73(6):1131S-1141S. PubMed ID: 11393191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Puerarin Rebuilding the Mucus Layer and Regulating Mucin-Utilizing Bacteria to Relieve Ulcerative Colitis.
    Wu Y; Li Y; Ruan Z; Li J; Zhang L; Lu H; Xu Z
    J Agric Food Chem; 2020 Oct; 68(41):11402-11411. PubMed ID: 32864960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beneficial role of the probiotic mixture Ultrabiotique on maintaining the integrity of intestinal mucosal barrier in DSS-induced experimental colitis.
    Toumi R; Abdelouhab K; Rafa H; Soufli I; Raissi-Kerboua D; Djeraba Z; Touil-Boukoffa C
    Immunopharmacol Immunotoxicol; 2013 Jun; 35(3):403-9. PubMed ID: 23638770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mucosal protection by phosphatidylcholine as new therapeutic concept in ulcerative colitis].
    Stremmel W
    Z Gastroenterol; 2013 Apr; 51(4):384-9. PubMed ID: 23585269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epithelial IL-18 Equilibrium Controls Barrier Function in Colitis.
    Nowarski R; Jackson R; Gagliani N; de Zoete MR; Palm NW; Bailis W; Low JS; Harman CC; Graham M; Elinav E; Flavell RA
    Cell; 2015 Dec; 163(6):1444-56. PubMed ID: 26638073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Butyrate enemas do not affect human colonic MUC2 and TFF3 expression.
    Hamer HM; Jonkers DM; Renes IB; Vanhoutvin SA; Kodde A; Troost FJ; Venema K; Brummer RJ
    Eur J Gastroenterol Hepatol; 2010 Sep; 22(9):1134-40. PubMed ID: 20461009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in goblet cell differentiation between Crohn's disease and ulcerative colitis.
    Gersemann M; Becker S; Kübler I; Koslowski M; Wang G; Herrlinger KR; Griger J; Fritz P; Fellermann K; Schwab M; Wehkamp J; Stange EF
    Differentiation; 2009 Jan; 77(1):84-94. PubMed ID: 19281767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic Inflammation in Ulcerative Colitis Causes Long-Term Changes in Goblet Cell Function.
    Singh V; Johnson K; Yin J; Lee S; Lin R; Yu H; In J; Foulke-Abel J; Zachos NC; Donowitz M; Rong Y
    Cell Mol Gastroenterol Hepatol; 2022; 13(1):219-232. PubMed ID: 34418586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mucosal healing in ulcerative colitis (UC)].
    Cazals-Hatem D
    Presse Med; 2015; 44(7-8):695-6. PubMed ID: 26049912
    [No Abstract]   [Full Text] [Related]  

  • 13. Luminal leptin activates mucin-secreting goblet cells in the large bowel.
    Plaisancie P; Ducroc R; El Homsi M; Tsocas A; Guilmeau S; Zoghbi S; Thibaudeau O; Bado A
    Am J Physiol Gastrointest Liver Physiol; 2006 Apr; 290(4):G805-12. PubMed ID: 16455789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphatidylcholine (lecithin) and the mucus layer: Evidence of therapeutic efficacy in ulcerative colitis?
    Stremmel W; Hanemann A; Ehehalt R; Karner M; Braun A
    Dig Dis; 2010; 28(3):490-6. PubMed ID: 20926877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reinforcing the mucus: a new therapeutic approach for ulcerative colitis?
    Gibson PR; Muir JG
    Gut; 2005 Jul; 54(7):900-3. PubMed ID: 15951531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of Mucosal p32/gC1qR/HABP1 Triggers Energy Deficiency and Impairs Goblet Cell Differentiation in Ulcerative Colitis.
    Sünderhauf A; Hicken M; Schlichting H; Skibbe K; Ragab M; Raschdorf A; Hirose M; Schäffler H; Bokemeyer A; Bettenworth D; Savitt AG; Perner S; Ibrahim S; Peerschke EI; Ghebrehiwet B; Derer S; Sina C
    Cell Mol Gastroenterol Hepatol; 2021; 12(1):229-250. PubMed ID: 33515804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intestinal tissue kallikrein-kallistatin profile in inflammatory bowel disease.
    Stadnicki A; Mazurek U; Plewka D; Wilczok T
    Int Immunopharmacol; 2003 Jul; 3(7):939-44. PubMed ID: 12810351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colonic mucus, smoking and ulcerative colitis.
    Pullan RD
    Ann R Coll Surg Engl; 1996 Mar; 78(2):85-91. PubMed ID: 8678464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucosal CXCR4+ IgG plasma cells contribute to the pathogenesis of human ulcerative colitis through FcγR-mediated CD14 macrophage activation.
    Uo M; Hisamatsu T; Miyoshi J; Kaito D; Yoneno K; Kitazume MT; Mori M; Sugita A; Koganei K; Matsuoka K; Kanai T; Hibi T
    Gut; 2013 Dec; 62(12):1734-44. PubMed ID: 23013725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defective post-transcriptional processing of MUC2 mucin in ulcerative colitis and in Crohn's disease increases detectability of the MUC2 protein core.
    Hanski C; Born M; Foss HD; Marowski B; Mansmann U; Arastéh K; Bachler B; Papenfuss M; Niedobitek F
    J Pathol; 1999 Jul; 188(3):304-11. PubMed ID: 10419600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.